Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,125 | -89,013 | -1,251 | -1,288 | -804 |
| Depreciation Amortization | 245 | 81 | N/A | 0 | N/A |
| Other Working Capital | 803 | 262 | 430 | 215 | 61 |
| Other Operating Activity | 142,951 | 82,652 | 14 | 50 | 22 |
| Operating Cash Flow | $-13,126 | $-6,018 | $-807 | $-1,023 | $-721 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | N/A | N/A | 0 | N/A |
| Purchase Sale Intangibles | -25,118 | -25,118 | N/A | N/A | N/A |
| Other Investing Activity | -25,118 | -25,118 | 0 | 0 | 0 |
| Investing Cash Flow | $-25,144 | $-25,118 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 113,174 | 113,174 | N/A | N/A | 850 |
| Common Stock Issued | -1,299 | N/A | N/A | N/A | 2 |
| Other Financing Activity | 0 | 0 | 0 | 1,902 | 0 |
| Financing Cash Flow | $111,875 | $113,174 | $N/A | $1,902 | $852 |
| Beginning Cash Position | 879 | 879 | 879 | 0 | N/A |
| End Cash Position | 74,484 | 82,917 | 72 | 879 | 131 |
| Net Cash Flow | $73,605 | $82,038 | $-807 | $879 | $131 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,126 | -6,018 | -807 | -1,023 | -721 |
| Capital Expenditure | -26 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -13,152 | -6,018 | -807 | -1,023 | -721 |